Fundraising Fox
Sensorium Therapeutics
Medford, US · Founded 2021 · Delaware corporation · 27 employees on LinkedIn · 9 known investors
Find your way into Sensorium Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Janice Kranz, PhD to introduce you to Jacob Hooker
You →Janice · together at Eikonizo Therapeutics →Jacob
Ask Jamie Chen to introduce you to Jerrold Rosenbaum
You →Jamie · together at Psy Therapeutics, Inc →Jerrold
Sign up to find every way you can get introduced to Sensorium Therapeutics
- Your email: who you already know at Sensorium Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sensorium Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
Founders & leadership
Sensorium Therapeutics was founded in 2021 by Jerrold Rosenbaum and Jacob Hooker.
Board
Investors · 9
How we know: Bonaventure Equity, LLC's portfolio page · Not right? Tell us
How we know: Hatteras Venture Partners's portfolio page · Not right? Tell us
How we know: Iter Investments's portfolio page · Not right? Tell us
How we know: Mission Biocapital's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
How we know: Palo Santo VC's portfolio page · Not right? Tell us
How we know: Route 66 Ventures's portfolio page · funding news · Not right? Tell us
How we know: Service Provider Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$60.5M disclosed across 3 rounds · 2021–2025
▶$26.8MraisedJul 2025 · 19 investors · PharmaceuticalsRule 506(b)
- Jerrold RosenbaumDirector
- Ryan KatzDirector
- Kevin LalandeDirector
- Richard SimonDirector
- Balkrishan GillDirector
- Alexandra GlucksmannDirector
- Jacob HookerExecutive Officer, Director
- Offering amount
- $58.5M
- Amount sold
- $26.8M
- Proceeds to insiders
- $531K
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$24.7MraisedDec 2023 · 64 investors · PharmaceuticalsRule 506(b)
- Richard SimonExecutive Officer, Director
- Pranav TadiExecutive Officer
- Jerrold RosenbaumDirector
- Kevin LalandeDirector
- Ryan KatzDirector
- Offering amount
- $24.8M
- Amount sold
- $24.7M
- Proceeds to insiders
- $750K
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$9MraisedJul 2021 · 47 investors · PharmaceuticalsRule 506(b)
- Richard SimonExecutive Officer, Director
- Jerrold RosenbaumDirector
- Pranav TadiExecutive Officer
- Offering amount
- $9M
- Amount sold
- $9M
- Proceeds to insiders
- $400K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Sensorium Therapeutics went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Sensorium Therapeutics.
In the news
Frequently asked questions
- What does Sensorium Therapeutics do?
- Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.
- Who founded Sensorium Therapeutics?
- Sensorium Therapeutics was founded by Jerrold Rosenbaum, Jacob Hooker in 2021.
- Who are Sensorium Therapeutics's investors?
- Sensorium Therapeutics's investors include Bonaventure Equity, LLC, Hatteras Venture Partners, Iter Investments, Mission Biocapital, Palo Santo VC, Route 66 Ventures, Service Provider Capital, Sante Health Ventures and 1 more.
- How much funding has Sensorium Therapeutics raised?
- Sensorium Therapeutics has disclosed $60.5M raised across 3 rounds.
- Where is Sensorium Therapeutics headquartered?
- Sensorium Therapeutics is headquartered in Medford, US.